Eiger BioPharmaceuticals, Inc.
PHARMACEUTICAL COMPOSITIONS COMPRISING LONAFARNIB AND RITONAVIR
Last updated:
Abstract:
Lonafarnib and ritonavir, or a pharmaceutically acceptable salt thereof, are used in combination to treat HDV infection. In one aspect, amorphous co-precipitates comprising lonafarnib, ritonavir, and a co-polymer are provided.
Status:
Application
Type:
Utility
Filling date:
19 Oct 2020
Issue date:
1 Apr 2021